Drug Development

Articles

The company announced the launch of its first-in-class Lynx CDR connectors at INTERPHEX 2016.

MilliporeSigma Introduces Multi-Use Disposable Sterile Connectors at INTERPHEX

Highly potent or cytotoxic drugs require special handling

Best Practice: Developing Drugs that are Highly Potent

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

The Subcommittee for Advanced Manufacturing of the National Science and Technology Council highlights biopharmaceutical manufacturing as an emerging priority.

US National Science and Technology Council Promotes Advanced Manufacturing

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Traditional methods of measuring the effectiveness of vaccines against the flu are called into question by new findings from the NIH.

NIH Study Identifies Better Parameter to Predict Flu Vaccine Effectiveness

Linker technology and drug combinations play an important role in the efficacy of ADCs.

Seattle Genetics Presents New Antibody-Drug Conjugate Data at AACR

The Office of Generic Drugs highlights the agency’s work to advance generic drugs.

FDA Releases Annual Report on Generics

Cornell researchers reveal that an existing FDA-approved drug can facilitate the delivery of other large molecules across the blood-brain barrier.

Researchers Discover a Method to Penetrate the Blood-Brain Barrier

The agency has announced the creation of the Combination Products Policy Council to address issues related to combination products.

FDA Creates Combination Products Council

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Even though the organizers of New York’s Tribeca Film Festival decided not to air the anti-vaccine film by discredited British researcher Andrew Wakefield, the so-called documentary is getting a healthy run and further perpetuating the myth of a link between childhood vaccination and autism.

Anti-Vaccine Movement Rears Its Ugly Head Again

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems.

Formulation and Drug Delivery